Patents by Inventor Caroline Berenguer-Daize

Caroline Berenguer-Daize has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs
    Patent number: 9474794
    Abstract: The invention relates to antibodies that bind to adrenomedullin and to proteins forming adrenomedullin receptors and to the uses thereof as drugs.
    Type: Grant
    Filed: August 30, 2011
    Date of Patent: October 25, 2016
    Assignees: Universite d'Aix-Marseille, Centre National de la Recherche Scientifique
    Inventors: Kamel Mabrouk, L'Houcine Ouafik, Carine Tesic, Denis Bertin, Caroline Berenguer-Daize, Pierre-Marie Martin
  • Diagnostic and Treatment of an Androgen-Independent Prostate Cancer
    Publication number: 20140308298
    Abstract: The present invention relates to a method for monitoring the tumor growth of an androgen-independent prostate cancer in a subject, by determining the amount of at least one adrenomedullin receptor and optionally adrenomedullin in a prostate cancer cell obtained from said subject. The present invention also relates to a pharmaceutical composition comprising an anti-adrenomedullin antagonist antibody and/or at least one anti-adrenomedullin receptor antagonist antibody for treating an androgen-independent prostate cancer.
    Type: Application
    Filed: November 2, 2012
    Publication date: October 16, 2014
    Applicants: UNIVERSITE D'AIX MARSEILLE, ASSISTANCE PUBLIQUE-HOPITAUX DE MARSEILLE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Institut National de la Sante et de la Recherche
    Inventors: Caroline Berenguer-Daize, Pierre-Marie Martin, Kamel Mabrouk, Denis Bertin, L'Houcine Ouafik
  • Antibodies that Bind to Adrenomedullin and to Adrenomedullin Receptors and the Uses Thereof as Drugs
    Publication number: 20130315912
    Abstract: The invention relates to antibodies that bind to adrenomedullin and to proteins forming adrenomedullin receptors and to the uses thereof as drugs.
    Type: Application
    Filed: August 30, 2011
    Publication date: November 28, 2013
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE D'AIX-MARSEILLE
    Inventors: Kamel Mabrouk, L'Houcine Ouafik, Carine Tesic, Denis Bertin, Caroline Berenguer-Daize, Pierre-Marie Martin